FDA approves pancreatic cancer drug that’s shown to improve survival

The Manila Times 27 Aug Philippines

WASHINGTON, D.C. — The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering US patients a more effective treatment against one of the deadliest types of cancer. FDA officials gave expedited approval to the first-of-a-kind pill, called daraxonrasib, which blocks a mutated protein that fuels tumor growth in more than 90 percent o

Aggregated from the leading newsrooms of the country. Every story links to its original source.